In tumor-bearing mice, pulmonary ILC2s, as well as tumor-infiltrating ILC2s adoptively transferred at a ratio of 1:60 relative to tumor cells, significantly enhance the infiltration of CD4+ and CD8+ T cells and eosinophils into the tumor microenvironment, thereby suppressing tumor growth. The gene discussed is CD8A; the disease is neoplasm.